Stocks Rise Ahead of Powell’s Comments
Investors weigh coronavirus treatment developments while seeking Fed guidance on economic downturn.
U.S. stocks advanced ahead of views from Federal Reserve policy makers on the health of the U.S. economy, and a flurry of earnings reports from major American companies.
The gains also coincided with a statement from Gilead Sciences saying that a clinical trial evaluating its drug remdesivir in coronavirus patients had concluded with a positive result, sending shares in the biotech company up sharply in premarket trading.
The S&P 500 rose 1.9%, while the Dow Jones Industrial Average...